logo-loader
viewFalcon Oil & Gas Ltd

Falcon Oil & Gas to receive US$3.7mln from NIS

NIS, which is part owned by Gazprom, agreed to pay the money in fulfilment of its contractual obligations.

shutterstock_153178391_565fedb72d07b.jpg
Falcon retains a 100% interest in the Mako Trough Licence in Hungary

--ADDS BROKER COMMENT--

Falcon Oil & Gas (LON:FOG, CVE:FO) is to receive US$3.7mln from former partner Naftna Industrija Srbije (NIS).

NIS, which is part owned by Gazprom, agreed to pay the money in fulfilment of its contractual obligations to a project in Hungary’s Mako Trough, Falcon said in a statement.

A termination agreement has now been signed for an oilfield services contract, which the companies previously entered into in 2013.

NIS drilled two of three wells agreed in the contract. Falcon had previously granted extensions to the deadline for the proposed project.

Falcon retains a 100% interest in the Mako Trough Licence in Hungary.

“This will serve to boost the company’s already stable cash position as it looks to progress its carried drilling programme in Australia,” said Sam Wahab, analyst at broker Cantor Fitzgerald.

Meanwhile, finnCap analyst Dougie Youngson said: “This situation has been ongoing for some considerable time so this is a positive outcome for Falcon and helps to strengthen its balance sheet.”

Quick facts: Falcon Oil & Gas Ltd

Price: 11.625 GBX

AIM:FOG
Market: AIM
Market Cap: £114.14 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Falcon Oil & Gas Ltd named herein, including the promotion by the Company of Falcon Oil & Gas Ltd in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: SkinBio signs commercial deal with chemical giant Croda

Headlines from the Proactive UK newsroom. SkinBioTherapeutics (LON:SBTX) has signed a commercial and manufacturing agreement for its Skinbiotix technology with speciality chemical giant Croda.  It is the first major deal for the product with Croda to design and manufacture a new active...

3 weeks, 3 days ago

2 min read